Dr Paul R. Palmer
Dr Paul R. Palmer MBa MSc CBiol
Owner and Founder of The Academy of Pharmaceutical Excellence
Paul joined the Pharmaceutical industry from school after 4 years part time dispensing in ahis fathers Pharmacy which put him off becoming a retail pharmacist. Smith and Nephew attracted him to join them with the incentive of a sponsored degree with no commitments. A big attraction with the prospects of university debts looming. Enjoying being in the industry he stayed with a philosophy of "if a job is worth doing its worth doing well". Yes this is a direct quote from 1986 when Tracy asked why he was doing such a good job cleaning the media bottles after sterilisation.
It hasn't always been plain sailing, after 5 redundancies he decided to start his own consultancy and has never looked back enjoying helping clients every day.
Dr Paul R. Palmer is a Pharmaceutical Consultant, Qualified Person (QP), and Auditor with four decades of experience in the pharmaceutical industry, ranging from Microbiology on the bench to sterilisation, process, equipment and computer system validation. A penchant for regulatory compliance he is often asked to guide his peers and supports those who are new to the industry with advice from how to's to what should they take next to advance their careers.
He holds a Doctorate, MBA, and MSc, and is named as a Qualified Person on multiple UK and EU manufacturing licences. Since entering the industry in 1986, Paul has built a reputation for delivering practical, high-impact solutions that enable organisations to achieve and sustain inspection readiness.
As the founder of Paul R Palmer Limited, he supports pharmaceutical companies globally with site licence applications, regulatory inspection preparation, deviation and CAPA optimisation, and the development of robust Pharmaceutical Quality Systems. His work is grounded in real-world execution—focused on outcomes, not theory.
Paul is also a lecturer on the Qualified Person programme, helping to develop the next generation of QPs by bringing clarity to complex regulatory expectations.
He is the creator of the Academy of Pharmaceutical Excellence, a forward-thinking training platform designed to modernise GMP education through scalable, practical, and technology-enabled learning.
Career Experience and Impact
Paul’s career spans senior leadership and technical roles across pharmaceutical manufacturing, including sterile products, biotechnology, radiopharmaceuticals, and global supply chains.
He has held positions such as Group Quality Director, Head of Quality, Quality Assurance Manager, and Qualified Person, leading multi-site operations and global quality functions. He has managed teams of up to 75 quality professionals and successfully hosted regulatory inspections, including MHRA inspections across GMP and GDP environments.
He has extensive experience in commercial and investigational medicinal products, including batch certification, supplier qualification, auditing of global contract manufacturers, and implementation of electronic Quality Management Systems across international organisations.
Paul has also played a key role in site establishment and licence acquisition, including supporting successful MHRA approvals for manufacturing sites that had previously failed inspection—demonstrating his ability to turn regulatory setbacks into operational success.
He is frequently engaged in situations where organisations are under regulatory pressure, need rapid remediation, or require experienced oversight of complex outsourced supply chains.
Early Career and Technical Depth
Paul’s career was built on a strong scientific and operational foundation within pharmaceutical and medical device manufacturing.
He began in laboratory roles specialising in microbiology, quality control, and validation, gaining hands-on experience in sterility assurance, aseptic processing, and terminal sterilisation. He progressed to lead microbiology validation and quality control functions, developing a deep understanding of product behaviour, process variability, and risk beyond documentation alone.
From early in his career, Paul was also responsible for third-party and subcontract manufacturing oversight, implementing control systems, qualifying suppliers, and ensuring compliance across externally manufactured products. This included establishing governance frameworks for outsourced supply and auditing contract manufacturers—long before outsourcing became the dominant industry model.
He developed extensive experience in internal and external GMP auditing, assessing manufacturing sites, supply chains, and distribution networks globally since the late 1990s, building a reputation as a rigorous and pragmatic auditor.
Philosophy and Differentiation
Paul is known for challenging conventional approaches to quality. He believes that many Pharmaceutical Quality Systems are designed to satisfy regulators rather than to serve the business—and has built a career on transforming these into systems that are both compliant and operationally effective.
He describes himself as “not a typical QP,” taking a facilitative approach that enables organisations to consistently achieve compliant outcomes rather than simply policing failures.
At the core of his work is a clear principle: the patient must always come first. This philosophy was strengthened through personal experience supporting a close family member through cancer treatment, reinforcing his commitment to ensuring medicines are safe, effective, and reliable.
Resilience, Leadership and Real-World Experience
Paul’s career has not been linear—and that is precisely where much of his strength comes from.
He has experienced multiple industry redundancies, navigated significant commercial challenges, and rebuilt his consultancy after coming close to bankruptcy. These experiences have shaped a pragmatic, results-driven approach grounded in reality rather than theory.
He has consistently demonstrated the ability to adapt, rebuild, and deliver under pressure, whether establishing new quality systems from scratch, leading global teams, or supporting organisations through critical regulatory challenges.
Paul is typically engaged when the stakes are high, timelines are tight, and failure is not an option.